Product Information
DELSTRIGO 100-300-300 MG TAB is a brand product labeled by Merck Sharp & Dohme LLC, priced at $92.7168 per EA under NDC 00006500701. Its NADAC has been published 154 times since Jul 19, 2023.
Strength
100; 300; 300 mg/1; mg/1; mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006500701
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA210807On Market Since
7/20/2018
Pharmacological Classes
Price Statistics
The NADAC for DELSTRIGO 100-300-300 MG TAB has been published 154 times since Jul 19, 2023, and over the history we have for it it has risen 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $92.7168 per EA |
|---|---|
| All-time high | $92.9143 (May 13, 2026) |
| All-time low | $82.6907 (Jul 19, 2023) |
| 52-week high | $92.9143 |
| 52-week low | $90.6516 |
| Median price | $86.8211 |
| Average price | $88.3123 |
| Largest weekly change | +5.0% (Jan 17, 2024) |
| Weeks tracked | 154 |
| Tracking since | Jul 19, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the doravirine, lamivudine, and tenofovir disoproxil fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DELSTRIGO 100-300-300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DELSTRIGO 100-300-300 MG TAB, manufactured by Merck Sharp & Dohme LLC, is $92.7168 per EA (NDC 00006500701), effective Jun 24, 2026.
How has the price of DELSTRIGO 100-300-300 MG TAB changed over time?
Over the history we have for it, the NADAC for DELSTRIGO 100-300-300 MG TAB has risen 12.1%. It has been tracked across 154 weekly CMS publications since Jul 19, 2023.
What are the highest and lowest recorded NADAC prices for DELSTRIGO 100-300-300 MG TAB?
Since Jul 19, 2023, the NADAC for DELSTRIGO 100-300-300 MG TAB has ranged from a low of $82.6907 (Jul 19, 2023) to a high of $92.9143 (May 13, 2026), with a median of $86.8211 per EA.
Are there cheaper alternatives to DELSTRIGO 100-300-300 MG TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DELSTRIGO 100-300-300 MG TAB, so no direct lower-cost alternative is listed.
Who manufactures DELSTRIGO 100-300-300 MG TAB?
DELSTRIGO 100-300-300 MG TAB (NDC 00006500701) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification